Research Article
Irreversible Electroporation in Patients with Pancreatic Cancer: How Important Is the New Weapon?
Figure 3
Forest plot of the pooled prevalence data of complete response at 2 months (a), partial response at 3 months (b), and progression at 3 months (c) among studies targeting the effect of IRE therapy in patients with PC.
(a) |
(b) |
(c) |